This inventor holds 1 USPTO granted patent. Top assignee: Symphar S.a.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Jean-Luc Thuillard
Introduction
Jean-Luc Thuillard is a notable inventor based in Saint-Cergue, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antineoplastic agents. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Jean-Luc Thuillard holds a patent for the "Use of phenol substituted diphosphonates as antineoplastic agents." This innovative approach aims to enhance the effectiveness of cancer therapies, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Thuillard has been associated with Symphar S.A., a company dedicated to pharmaceutical advancements. His role at Symphar has allowed him to focus on research and development, contributing to the company's mission of improving healthcare solutions.
Collaborations
He has collaborated with notable colleagues, including Eric Joseph Niesor and Craig Leigh Bentzen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jean-Luc Thuillard's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of antineoplastic agents, highlight the importance of research and collaboration in advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile